Congratulations to our team in Staszów, Poland, and Katarzyna Wawrzyniec-Lis, MD, for being the top global enroller for Boehringer Ingelheim’s Phase 3 cardiovascular safety study for patients with obesity! Velocity is supporting this study at more than 20 sites across the U.S., Poland, and Germany.
